Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediclinic International is a leading international private healthcare services group with operations in Southern Africa, Switzerland, and the United Arab Emirates. Founded in 1983, the company provides a wide range of multi-disciplinary specialist healthcare services through its extensive network of hospitals and clinics. In May 2023, the company was acquired by a consortium comprising Remgro Limited and MSC, leading to its delisting from public exchanges. Mediclinic focuses on delivering high-quality clinical care and patient safety across its diverse geographic footprint. The group's portfolio includes the Hirslanden hospital group in Switzerland and significant operations in the Middle East.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediclinic International.